Atorvastatin Plus Ezetimibe on Coronary Plaque Progression

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 400 participants.

Also called NCT01086020

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 400 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01086020
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01086020. Randomized; no masking; primary purpose treatment. Start 2010-01 (registry gives no type); primary completion 2011-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Atorvastatin Plus Ezetimibe on Coronary Plaque Progression
Acronym
AEPP
Intervention (Drug)
atorvastatin
Intervention (Drug)
atorvastatin plus ezetimibe
Lead sponsor
Shanghai Jiao Tong University School of Medicine (class: other)

Record details

Record id
cardio:ct-nct01086020
Content hash
62a44d19a2f7849d951446ee94f5826b0987a0a56df12247e63d8bbec5bac83e